An open-label titration followed by a randomized, double-blind, placebo-controlled study to assess the efficacy, tolerability, and safety of oxymorphone extended release tablets in opioid-experienced patients with chronic low back pain
Phase of Trial: Phase III
Latest Information Update: 17 Aug 2008
At a glance
- Drugs Oxymorphone (Primary)
- Indications Back pain
- Focus Therapeutic Use
- 17 Aug 2008 Results reported at the 12th World Congress on Pain in August 2008.
- 22 Nov 2005 New trial record.